Hanmi Science Co., Ltd. (KRX:008930)
44,700
+2,100 (4.93%)
At close: Feb 4, 2026
Hanmi Science Market Cap
Hanmi Science has a market cap or net worth of 3.03 trillion as of February 5, 2026. Its market cap has increased by 52.82% in one year.
Market Cap
3.03T
Enterprise Value
3.16T
Revenue
1.34T
Ranking
n/a
PE Ratio
40.27
Stock Price
44,700.00
Market Cap Chart
Since August 28, 1995, Hanmi Science's market cap has increased from 36.00B to 3.03T, an increase of 8,307.80%. That is a compound annual growth rate of 15.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 3.11T | 26.90% |
| Dec 30, 2025 | 2.45T | 23.09% |
| Dec 30, 2024 | 1.99T | -25.17% |
| Dec 28, 2023 | 2.66T | 20.78% |
| Dec 29, 2022 | 2.21T | -39.49% |
| Dec 30, 2021 | 3.65T | -27.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.96T |
| Celltrion | 45.40T |
| ALTEOGEN | 21.55T |
| Sam Chun Dang Pharm. | 12.30T |
| ST Pharm | 3.23T |
| Celltrion Pharm | 3.11T |
| Hugel | 2.81T |
| OliX Pharmaceuticals | 2.78T |